Indeed, glioma-induced microglia activation toward a tumor supporting phenotype is coupled to a reduction of basal microglial CASP3 activity, through thioredoxin-2-mediated S-nitrosylation of the enzyme. The gene discussed is CASP3; the disease is central nervous system cancer.